How many 8-K filings has Exagen Inc. filed?

Exagen Inc. (XGN) has 10 8-K (Current Event Report) filings on record, spanning Jan 2024 to May 2026.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Exagen Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Exagen Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Exagen Inc. (XGN) — 8-K Filings

All 8-K filings from Exagen Inc.. Browse 10 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (10)

8-K Filing — May 11, 2026
Exagen Inc. Files 8-K on Officer Changes and More — Jul 17, 2025 Risk: medium
Exagen Inc. filed an 8-K on July 17, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain of
Exagen Inc. Reports on Shareholder Vote Matters — Jun 11, 2025 Risk: low
Exagen Inc. filed an 8-K on June 11, 2025, reporting on matters submitted to a vote of security holders on June 10, 2025. The filing details the company's corpo
Exagen Inc. Files 8-K — May 9, 2025 Risk: low
Exagen Inc. filed an 8-K on May 9, 2025, reporting an event that occurred on May 8, 2025. The filing is related to "Other Events" and "Financial Statements and
Exagen Inc. Files 8-K: Material Agreement, Other Events — May 8, 2025 Risk: medium
Exagen Inc. filed an 8-K on May 8, 2025, reporting on events that occurred on May 7, 2025. The filing indicates the entry into a material definitive agreement,
Exagen Inc. Files 8-K: Material Agreements & Equity Sales — Apr 28, 2025 Risk: medium
On April 25, 2025, Exagen Inc. entered into a material definitive agreement, likely related to its financial obligations. The company also reported on the creat
Exagen Inc. Files 8-K on Financials and Operations — Jan 13, 2025 Risk: low
Exagen Inc. filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition, as well as other events. The filing also includes
Exagen Inc. Files 8-K on Shareholder Vote Matters — Jun 11, 2024 Risk: low
Exagen Inc. filed an 8-K on June 11, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 10, 2024. The company, forme
Exagen Appoints Dr. Dennis Horvath as CEO — Apr 26, 2024 Risk: medium
Exagen Inc. announced on April 22, 2024, the appointment of Dr. Dennis Horvath as its new Chief Executive Officer and a member of the Board of Directors. Dr. Ho
EXAGEN Files 8-K on Financial Condition, Operations — Jan 8, 2024
EXAGEN INC. filed an 8-K on January 8, 2024, reporting an event that occurred on January 7, 2024, related to 'Results of Operations and Financial Condition' and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX